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Abstract 
GABAA receptors (GABAARs) are ligand-gated Cl

 channels mediating most of fast inhibitory 
neurotransmission in the CNS. Multiple GABAAR subtypes are assembled from a family of 19 subunit 
genes, raising the question of the significance of this heterogeneity. In this review, we discuss the 
evidence that GABAAR subtypes represent distinct receptor populations with a specific spatio-
temporal expression pattern in developing and adult CNS, being endowed with unique functional and 
pharmacological properties, as well as being differentially regulated at the (post-) transcriptional and 
translational levels. GABAAR subtypes are targeted to specific subcellular domains to mediate either 
synaptic or extrasynaptic transmission, and their action is dynamically regulated by a vast array of 
molecular mechanisms to adjust the strength of inhibition to the changing needs of neuronal networks. 
These adaptations take place not only by changing the gating or kinetic properties of GABAARs, but 
also by modifying the postsynaptic scaffold organized by gephyrin to anchor specific receptor 
subtypes at postsynaptic sites.  The significance of GABAAR heterogeneity is particularly evident 
during CNS development and adult neurogenesis, with different receptor subtypes fulfilling distinct 
steps of neuronal differentiation and maturation. Finally, the analysis of the specific role of GABAAR 
subtypes reveals their implication in the pathophysiology of major CNS disorders and opens novel 
perspectives for therapeutic intervention. In conclusion, GABAAR subtypes represent the substrate of a 
multi-facetted inhibitory neurotransmission system, which is dynamically regulated and performs 
multiple operations contributing globally to proper development, function and plasticity of the CNS. 
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Introduction 
GABAA receptors (GABAARs) belong to the family of Cys-loop ligand-gated ion channels, along with 
nicotinic acetylcholine receptors, glycine receptors (GlyR), and serotonin type 3 receptors (5-HT3), 
which form pentameric channels carrying two extracellular ligand binding sites (Olsen & Sieghart, 
2008). Being permeable for Cl

 ions, GABAARs mediate most of the inhibitory action of GABA in the 
CNS. By virtue of their ubiquitous expression in neurons (and possibly glial cells; (Passlick et al., 
2013)), GABAAR contribute to all CNS functions, including sensory and motor processing, central 
autonomic control, sleep-wakefulness, emotions, and cognition. Clinically, the main relevance of 
GABAAR relates to their exclusive targeting by benzodiazepines (and other ligands with high affinity 
for the benzodiazepine binding site), used for their anxiolytic, sedative, anticonvulsant, and muscle 
relaxant properties. Benzodiazepine site ligands act as allosteric modulators, and, due to their 
extraordinary selectivity, produce no other direct action in the CNS. GABAARs are also the target of 
general anesthetics (Rudolph & Antkowiak, 2004), ethanol, and endogenous modulators, notably 
endozepines (Christian et al., 2013) and neurosteroids (Hosie et al., 2006). These ligands, in large part 
derived from glial cells, are considered to be crucial regulators of neuronal function and excitability 
under both physiological and pathological conditions and represent promising novel targets for 
specific neurological and psychiatric indications (reviewed in (Belelli & Lambert, 2005; Carver & 
Reddy, 2013)). 
In the early ‘90s, the identification of 19 genes encoding GABAAR subunits (1-6, 1-3, 1-3, , 
, , , 1-r3) in mammals, coupled with the demonstration that recombinant receptors assembled with 
an , a  and the 2 subunit variant were functionally and pharmacologically similar to native 
GABAARs, raised the question of the significance of GABAAR heterogeneity. This question is still 
largely unresolved, but the evidence available suggests that GABAAR subtypes, differing in subunit 
composition, represent distinct functional entities, imparted with specific functions and 
pharmacological profile, and with a unique spatio-temporal mRNA and protein expression pattern. In 
this review, we will discuss this evidence, based on four fundamental observations made since the 
existence of GABAAR subtypes was established: 
A first major thrust in understanding the function of GABAAR subtypes and the relevance of their 
molecular heterogeneity has been the recognition that they mediate two fundamentally distinct forms 
of inhibitory transmission, which depend on their localization, either postsynaptic (mediating fast, 
high amplitude phasic currents upon quantal presynaptic GABA release) or extrasynaptic (mediating 
low amplitude but persistent (tonic) currents activated by ambient GABA) (reviewed in (Farrant & 
Nusser, 2005; Belelli et al., 2009; Brickley & Mody, 2012)) (see Box 3). The significance of tonic 
inhibition, in particular for the control of neuronal excitability and plasticity, is now gaining 
widespread recognition. Importantly, these two major populations of GABAAR are molecularly 
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distinct, with postsynaptic receptors containing mainly the 1, 2, 3 subunit, along with  subunit 
variants and the 2 subunit, and extrasynaptic receptors containing 4, 5, 6 subunit, often along 
with  (instead of 2). This observation implies that mechanisms of subcellular targeting of GABAAR 
subtypes are subunit-specific, and can vary between CNS regions and developmental stages. The 
crucial role played by the postsynaptic scaffold organized by gephyrin for post-synaptic targeting and 
confinement of some GABAARs in GABAergic postsynaptic densities (PSDs) is now widely 
recognized, albeit poorly understood (Fritschy et al., 2012; Tretter et al., 2012). Further, there is ample 
evidence for modulation of both postsynaptic and extrasynaptic GABAARs by multiple 
posttranslational mechanisms regulating single channel functional properties, trafficking (exo- and 
endocytosis, degradation), cell surface mobility and synaptic confinement. Thereby, these mechanisms 
have a major impact on the strength of GABAergic transmission in response to changes in network 
function, and they represent a major facet of GABAergic synapse plasticity (Hines et al., 2011; 
Luscher et al., 2011a; Connelly et al., 2013a). 
A second major advance was the demonstration, using gene targeting techniques, that the spectrum of 
diazepam’s actions is elicited by distinct GABAAR subtypes, distinguished by their  subunit variant 
(Rudolph & Möhler, 2004). The logical consequence of these findings is that these distinct GABAARs 
are localized in different neuronal circuits, even when they are co-expressed within neurons or within 
specific brain areas (see Box 2). An important concept emerging along this line is that GABAergic 
interneurons are likewise specialized to control the activity of principal cells in a circuit-specific 
manner (Klausberger & Somogyi, 2008). This highly sophisticated organization raises the possibility 
that multiple forms of inhibitory neurotransmission, engaging specific interneurons and GABAAR 
subtypes, operate in parallel in neuronal circuits involved in concurrent tasks. The possibility to probe 
interneuron function in vivo using optogenetic tools has substantially advanced our understanding of 
their role and functional specialization (Sohal et al., 2009; Pfeffer et al., 2013; Zhu et al., 2013). 
A third fundamental insight into GABAAR function is their dependence on ionic mechanisms, 
involving both Cl

 and HCO3

 ions (Blaesse et al., 2009). Therefore, the effects of GABAARs on the 
resting membrane potential, independently of their subunit composition, are determined by the action 
of KCl co-transporters and carbonic anhydrases (see Box 4). It has been recognized early that the 
expression of KCC2, the main Cl

 extrusion transporter in mature neurons (Kaila, 1994), is 
developmentally regulated, giving rise to the concept of a functional “switch” from depolarizing to 
hyperpolarizing GABAAR actions during ontogeny (Ben-Ari, 2002), with wide ranging consequences 
to our understanding of GABA function, as well as clinical use of GABAAR-modulating drugs in 
infants (Pavlov et al., 2013).  
Fourth, it is now well established that GABAAR-mediated transmission regulates multiple steps of 
neuronal development and maturation during ontogenesis and adult neurogenesis, including control of 
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stem/precursor cell proliferation, cell fate decision, migration of precursor cells, survival of immature 
neurons, dendritic growth, and synaptogenesis (reviewed in (Platel et al., 2007; Dieni et al., 2013)). 
Accordingly, it is being increasingly recognized that perturbations of GABAAR function during 
ontogeny or after a lesion, notably during critical periods of plasticity, can have long lasting effects on 
CNS circuit structure and function, potentially contributing to the pathophysiology of neurological and 
psychiatric disorders, including epilepsies, chronic pain, neurodevelopmental disorders, mood 
disorders, and schizophrenia (Bavelier et al., 2010; Lewis, 2012).  
Here, we will review the relevance of GABAAR heterogeneity for the regulation of GABAergic 
neurotransmission and GABAergic synaptic plasticity, and its potential impact for the 
pathophysiology of major neurological and psychiatric diseases, notably disorders linked to abnormal 
GABAergic function during brain development. We will highlight recent progress and discuss major 
roadblocks on the way to better understand the diversity of GABAAR regulation in health and disease. 
To do so, we will briefly introduce the molecular heterogeneity of GABAergic synapses, prior to 
discussing mechanisms regulating GABAARs in the context of GABAergic synaptic plasticity. Next, 
we will highlight the relevance of GABAAR subtypes for regulating neuronal development, and 
finally, for the pathophysiology of neurological and psychiatric diseases linked to abnormal 
GABAergic transmission.  
Composition and localization of major GABAA receptor subtypes 
The subunit composition of major GABAAR subtypes is well established on a regional level 
(immunoprecipitation using extracts from whole brain or a specific brain region), and there is general 
agreement that the most likely subunit stoichiometry is 2/2/ (the latter being sometimes substituted 
by  or ) (Boileau et al., 2005; Olsen & Sieghart, 2008; Patel et al., 2013). The existence of receptors 
containing / subunits only, as well as other stoichiometries (e.g. 2//2, 2//2) is probable 
(Jones & Henderson, 2013). Furthermore, the rules governing the formation of pentameric complexes 
are by far not fully elucidated. Functional GABAARs, with the pharmacological profile of native 
receptors, are formed by pentameric assembly of 2/2/, whereby the  and  subunits can be either 
identical or different. The 2 subunit can be substituted by 1 or 3 (present at low abundance and/or 
with a restricted expression pattern) or by , and possibly  subunits. There is consensus, therefore, 
that at least 3 dozen distinct GABAAR subtypes exist in CNS neurons (Olsen & Sieghart, 2008). In 
vitro expression of / subunits only, or targeted deletion of an  subunit gene in vivo, prevent 
assembly and/or surface targeting of a functional GABAAR complex, thereby providing the 
opportunity to remove specific GABAAR subtypes by inactivating a single  subunit gene (see Box 1). 
The most detailed information on the regional distribution of 18 GABAAR subunit mRNAs in mouse 
brain, determined by non-radioactive in situ hybridization with cellular resolution, is available in the 
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Allen Brain Atlas (http://mouse.brain-map.org). These data confirm original studies about the 
distribution of abundant subunits (1-6, 1-3, 2) (Laurie et al., 1992; Wisden et al., 1992) and 
provide detailed information about subunits expressed either at low abundance in numerous regions 
throughout the neuraxis, such as 3, or at high abundance in specific regions, such as  in the 
amygdala, basal forebrain, locus coeruleus (and other noradrenergic cell groups). According to the 
Allen Brain Atlas, the 1-2 mRNAs (corresponding to GABAC receptors) are restricted to the 
superficial layers of the superior colliculus and the  subunit mRNA is undetectable in adult mouse 
brain. 
Immunohistochemically, the distribution of ten subunits (1-6, 2-3, 2, ) has been analyzed in 
detail, on the regional and sometimes cellular level, and validated by targeted gene deletion (Fritschy 
& Mohler, 1995; Nusser et al., 1999; Peng et al., 2002; Chandra et al., 2006; Hörtnagl et al., 2013). 
There is also information available for the 1 and 1 subunit, which confirms in situ hybridization 
data. According to these studies, it is well apparent that the six  subunit variants largely correspond 
to distinct GABAAR subtypes  notwithstanding the possibility to find two different  subunits in a 
substantial fraction of GABAARs (Balic et al., 2009)  each with a specific distribution pattern that 
overlaps only partially with other  subunits (Figure 1). The same holds true for the  subunit variants, 
with 2 and 3 overlapping to a large extent with the 1 and 2 subunits, respectively (whereas 1 is 
expressed at lower abundance in numerous brain regions). The 2 subunit, in line with its association 
with the vast majority of GABAAR subtypes, is ubiquitously expressed; in contrast, the 1 subunit 
appears to have a highly restricted distribution, being most abundant in hypothalamus, amygdala, and 
parts of basal ganglia, as well as the inferior olivary nucleus. Finally, the  subunit, which forms 
GABAAR located extrasynaptically (see Box 3), largely overlaps with the 4 subunit in the forebrain 
and with 6 in the cerebellum.  
So far, however, there are only few CNS regions in which the GABAAR subunit repertoire and their 
cellular/subcellular distribution have been analyzed in some detail by immunohistochemistry. These 
include the hippocampal formation (notably CA1 subfield, which exhibits a remarkable heterogeneity 
with expression of at least 11 subunits), neocortex, olfactory bulb, parts of the thalamus (notably, 
ventrobasal complex, lateral geniculate nucleus, and reticular nucleus), cerebellum, and spinal cord 
dorsal horn.  
******************************* 
* Box 1 approximately here * 
******************************* 
On the subcellular level, a distinction between postsynaptic and extra-synaptic GABAARs can be 
made, based on the appearance of staining in weakly fixed tissue (see Box 1). Postsynaptic receptors 
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form brightly stained clusters, which co-localize with postsynaptic markers, such as gephyrin and 
neuroligin2, and are apposed to VGAT-positive presynaptic terminals (Fig. 2A). The reminder of the 
staining, besides these clusters, represents receptors dispersed at the cell surface, as well as the 
metabolic pool of receptors localized in the cytoplasm. Extrasynaptic receptors fail to form clusters, 
and the staining is of uniform intensity, with a “powdery” appearance in the neuropil, suggesting a 
widespread distribution on dendritic branches (Fig. 2B). Accordingly, these structures exhibit no 
obvious relationship with the distribution of either gephyrin or GABAergic axon terminals (Fig. 2B). 
As discussed below, presynaptic receptors localized in axons and axon terminals represent a distinct 
subset of extrasynaptic receptors, with specialized functions. 
Despite scant morphological evidence from immunohistochemical studies, there is strong functional 
support for the existence of GABAARs located on axons and presynaptic terminals (Grasshoff et al., 
2007; Trigo et al., 2008; Long et al., 2009; Witschi et al., 2011). A prominent exception is a 
population of GABAARs, readily detected immunohistochemically for the presence of 2 subunit, 
located on the axon initial segment of cortical neurons, typically clustered in rows of synapses 
innervated by axo-axonic interneurons (Nusser et al., 1996; Fritschy et al., 1998; Panzanelli et al., 
2011). Functionally, these GABAARs correspond to postsynaptic receptors anchored by gephyrin, and 
their activation contributes to the genesis of -oscillations (Tukker et al., 2007). In contrast to axo-
axonic synapses, most presynaptic GABAARs located on distal axons and terminals are hardly 
detectable by immunohistochemistry. They nevertheless play a key role in the control of axon 
potential transmission, neuronal synchronization, regulation of transmitter release, and mediation of 
presynaptic afferent depolarization (Trigo et al., 2008; Long et al., 2009; Ruiz et al., 2010; Wakita et 
al., 2013). While their subunit composition is unknown, it might be inferred from the repertoire of 
subunit mRNAs expressed by the cell of origin of these axons. We have characterized recently a 
population of GABAAR on primary afferent terminals in the spinal cord, containing 2 and 3 
subunits, that are crucially involved in the anti-hyperalgesic action of diazepam (Witschi et al., 2011; 
Paul et al., 2012). 
******************************* 
* Box 2 approximately here * 
******************************* 
Molecular organization of GABAergic synapses 
The subcellular localization of GABAARs is intimately linked to the molecular organization of 
GABAergic synapses, with specific proteins of the PSD contributing to trafficking and anchoring 
GABAARs in a subtype-specific manner. It has been recognized early that GlyRs, which are 
homologous to GABAARs, are localized at postsynaptic sites (Triller et al., 1985), owing to their high 
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affinity binding to the scaffolding protein gephyrin (Pfeiffer et al., 1982; Kirsch et al., 1993), which 
interacts with the cytoskeleton. The demonstration that the majority of postsynaptic GABAARs also 
are clustered with gephyrin took longer to be obtained (Sassoè-Pognetto et al., 1995; Sassoè-Pognetto 
et al., 2000), in part because gephyrin was considered to be present only at glycinergic synapses, and 
in part because GABAARs do not bind gephyrin with high affinity. Based on the evidence available to 
date, the 1, 2, and 3 subunits, as well as possibly 2 and 3, can interact directly with gephyrin 
via motives located in their main intracellular loop (Tretter et al., 2008; Mukherjee et al., 2011; Tretter 
et al., 2011; Kowalczyk et al., 2013), and, therefore, can be clustered postsynaptically. Conversely, 
GABAAR containing the 4, 5, or 6 subunit are localized predominantly extrasynaptically (Nusser 
et al., 1998; Chandra et al., 2006; Panzanelli et al., 2011). The 4 and 6 subunits  as well as 1 in 
specific interneurons (Mann & Mody, 2010; Milenkovic et al., 2013)  are frequently associated with 
the  subunit, which substitutes for 2 (see Box 3). However, extra- versus postsynaptic targeting of 
GABAARs appear to depend on motifs present in  subunit variants, as seen by comparing 
recombinant 2- and 6-GABAARs containing either 2 or  subunit (Wu et al., 2012). 
The finding that targeted deletion of the 2 subunit abolishes postsynaptic clustering of both, 
GABAARs and gephyrin, highlighted the interdependence between receptors (rather than individual 
subunits) and the gephyrin scaffold for proper localization at the cell surface (Essrich et al., 1998; 
Schweizer et al., 2003). Likewise, targeted deletion of Gphn (encoding gephyrin) confirmed its key 
role for postsynaptic clustering of GlyRs and GABAARs (Feng et al., 1998). These observations 
triggered intense research into elucidating the functions of gephyrin, and identifying proteins 
regulating GABAAR trafficking and GABAergic synapse formation (reviewed in (Luscher et al., 
2011a; Fritschy et al., 2012; Tretter et al., 2012)). These molecules include, in particular, collybistin, a 
Rho-GEF identified as direct binding partner of gephyrin, mediating its translocation to the cell 
surface (Kins et al., 2000), neuroligin2 (NL2), which interacts transsynaptically with neurexin 
isoforms (Varoqueaux et al., 2004; Kang et al., 2008) (see Fig. 3), as well as an array of proteins 
regulating GABAAR biogenesis, cell surface trafficking, endocytosis and degradation (Jacob et al., 
2008; Luscher et al., 2011a; Vithlani et al., 2011).  
Gephyrin: This phylogenetically ancient, highly conserved multi-functional molecule, is responsible 
throughout the living kingdom for Moco biosynthesis (Stallmeyer et al., 1999). Moco activates 
Molybdenum enzymes, whose functions are essential for survival (Schwarz et al., 2009). Gephyrin 
comprises two main catalytic domains (G and E), which in bacteria are encoded by two distinct genes 
(MogA and MoeA); in plants, the domains are fused, and in vertebrates, they are interconnected by a 
flexible linker (or central domain), which carries numerous sites for posttranslational modifications 
and interaction with partner proteins (reviewed in (Fritschy et al., 2008)). The domain organization of 
mammalian gephyrin not only ensures optimal Moco synthesis, but also allowed the emergence of 
novel, neuron-specific functions for the regulation of GlyR and GABAAR clustering (Belaidi & 
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Schwarz, 2013). Whereas the structure of gephyrin is not fully resolved, current evidence suggests 
formation of trimers (Sander et al., 2013), which organize themselves in a highly ordered 
supramolecular complex anchoring GABAARs in the plasma membrane and interacting with effector 
proteins (including NL2 and collybistin) and the cytoskeleton (Fig. 3) (reviewed in (Tyagarajan & 
Fritschy, 2014)).  
Postsynaptic clustering of gephyrin by auto-aggregation at GABAergic (and glycinergic synapses) 
represents a process fundamentally different from scaffold formation in the PSD of glutamatergic 
synapses, where PSD-95 and its homologues assemble a modular scaffold and interact with their 
partners by means of the PDZ interaction domain (Kennedy, 2000; Sheng & Sala, 2001). In 
GABAergic PSDs, most proteins lack a PDZ domain; therefore, there must be molecular mechanisms 
specifically enabling gephyrin scaffold formation at postsynaptic sites. Identifying these mechanisms 
is complicated by the fact that biochemical purification of GABAergic PSDs has not been achieved so 
far, whereas glutamatergic PSDs are highly enriched in synaptosomal fractions (Husi & Grant, 2001). 
Therefore, there are only limited proteomic data of inhibitory PSDs yet (Heller et al., 2012), and the 
possibility exists that major players involved in scaffold formation and regulation at GABAergic 
synapses are not yet identified. 
A major insight from recent studies was the finding that posttranslational modifications of gephyrin, 
mainly via phosphorylation, regulate its clustering properties, and thereby, the structural and 
functional properties of GABAergic synapses (Tyagarajan & Fritschy, 2014). This regulation is 
coupled to complex interactions with collybistin and NL2 (see below), contributing to GABAergic 
synapse formation and their dynamic regulation by activity-dependent mechanisms. Therefore, 
gephyrin emerges as a key element of a signaling hub regulating GABAergic function and plasticity in 
health and disease.  
It is of note that postsynaptic gephyrin clustering is not an intrinsic property of this protein, but it 
depends strictly on the presence of GABAAR subtypes with which gephyrin (and possibly additional 
proteins) can interact. Therefore, the loss of postsynaptic currents in 1- and 2-KO mice also leads to 
disruption of gephyrin postsynaptic clustering (Fritschy et al., 2006; Kralic et al., 2006; Pallotto et al., 
2012). Despite these crucial bidirectional interactions, gephyrin-independent GABAAR clustering at 
postsynaptic sites has been observed, both in vitro and in vivo (Kneussel et al., 2001; Levi et al., 2002; 
Panzanelli et al., 2011), pointing to alternative pathways regulating their synaptic localization. One of 
these mechanisms might be afforded by the dystrophin-glycoprotein complex (DGC), which is present 
selectively in a subset of GABAergic synapses in cortical neurons and cerebellar Purkinje cells 
(reviewed in (Fritschy et al., 2012)). Indeed, we have shown in 2-KO mice that postsynaptic clusters 
of 1-GABAARs and NL2 remain selectively associated with the DGC, but not with gephyrin, in 
perisomatic synapses of CA1 pyramidal cells (Panzanelli et al., 2011). A possible molecular link 
holding these proteins together is provided by synaptic scaffolding molecule (S-SCAM), which 
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interacts with both, dystrophin and NL2 (Sumita et al., 2007). Interestingly, the cell adhesion molecule 
IgSF9b, interacting with S-SCAM and NL2, has recently been identified to promote formation of 
GABAergic synapses, in particular in cortical interneurons, where it is most strongly expressed (Woo 
et al., 2013). 
A recent study using super-resolution microscopy to analyze the molecular organization of inhibitory 
PSDs provided a first quantification of the number of gephyrin molecules present per synapse, and 
demonstrated that the number of both GlyRs and GABAARs at the synapse depend on gephyrin 
abundance (Specht et al., 2013). A possible difference in the molecular organization of these synapses 
emerged from the observation that silencing neuronal cultures with tetrodotoxin for 48 h affected the 
synaptic enrichment of GABAARs, but not GlyRs.  
******************************* 
* Box 3 approximately here * 
******************************* 
Collybistin is a neuron-specific guanine nucleotide exchange factor that activates the small Rho 
GTPases CDC-42 and TC-10 (Mayer et al., 2013), and binds gephyrin at an identified site. Loss of 
GABAAR and gephyrin clustering occurs in a cell type-specific manner in collybistin-KO mice, 
unraveling the essential function of this protein at GABAergic synapses (Papadopoulos et al., 2007; 
Papadopoulos et al., 2008). The effect can be reproduced in cultured neurons upon over-expression of 
a collybistin isoform unable to interact with membrane phospholipids (via its PH domain) (Reddy-Alla 
et al., 2010; Tyagarajan et al., 2011a). In these experiments, expression of constitutively active CDC-
42 restored gephyrin clustering, indicating that it probably operates down-stream of collybistin 
(Tyagarajan et al., 2011a). However, elucidating the function(s) of collybistin and its effectors is 
rendered complicated by the existence of collybistin splice variants, carrying or lacking an N-terminal 
SH3 domain (collybistinSH3+ and collybistinSH3, respectively), because collybistinSH3+ has been 
reported to be an inactive form that needs to be activated in order to contribute to gephyrin and 
GABAAR clustering (Poulopoulos et al., 2009). The nature of this activation presumably involves a 
conformational change that enhances binding of the PH domain to membrane phospholipids (Figure 
3). It has been proposed, for example, that binding of GABAAR 2 or 3 subunit to collybistin, in 
conjunction with gephyrin, facilitates gephyrin cluster formation (Saiepour et al., 2010). Likewise, 
binding of NL2 to the SH3 domain was suggested to activate collybistin and thereby enable gephyrin 
clustering (Poulopoulos et al., 2009). However, targeted deletion of NLGN2 does not abolish gephyrin 
clustering and collybistin over-expression in neurons strongly stimulates gephyrin clustering 
independently of the presence/absence of the SH3 domain (Chiou et al., 2011; Tyagarajan et al., 
2011a), suggesting alternative mechanisms. Among these, the small GTPase TC-10 was shown 
recently to activate collybistin upon interaction with the PH domain, thereby enhancing gephyrin 
clustering in cultured neurons (Mayer et al., 2013). 
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Neuroligin 2: There are four neuroligin isoforms encoded by distinct genes (NLGN1-NLGN4) 
(Bolliger et al., 2001). These proteins, anchored postsynaptically by means of a single transmembrane 
domain, interact with presynaptic neurexins. This interaction is strongly synaptogenic, even in non-
neuronal cells, upon over-expression in vitro (Scheiffele et al., 2000; Graf et al., 2004; Chih et al., 
2005). NL2 is selectively located at GABAergic synapses (Varoqueaux et al., 2004) and NLGN4 at 
glycinergic synapses ((Hoon et al., 2011); but see (Soto et al., 2011)), whereas NLGN1 is selective for 
glutamatergic synapses (Song et al., 1999) and NLGN3 is found in both glutamatergic and 
GABAergic (Budreck & Scheiffele, 2007). NLGNs have raised considerable attention because they 
are associated with autism-spectrum disorders and other forms of mental retardation (reviewed in 
(Südhof, 2008)), as well as schizophrenia (Sun et al., 2011). Their specific in vivo role is not yet fully 
elucidated, in part because of functional redundancy with other synaptogenic molecules (Varoqueaux 
et al., 2006), and because their functions (and localization) are modulated by complex interaction with 
neurexin isoforms (Futai et al., 2013), post-translational modifications (Peixoto et al., 2012; Suzuki et 
al., 2012; Giannone et al., 2013), and homo- and heterodimerization (Poulopoulos et al., 2012; 
Shipman & Nicoll, 2012). In particular, it is not known whether NLGNs interact directly with 
GABAARs. Nevertheless, NL2-KO exhibit specific reduction of perisomatic GABAergic synapses in 
principal neurons of the hippocampal formation, associated with reduction of inhibitory currents and 
increased network excitability (Jedlicka et al., 2011). 
It should be noted that while NL2 is generally considered to be upstream in the chain of molecular 
events leading to formation of GABAergic synapses (Dong et al., 2007; Poulopoulos et al., 2009), in 
vitro evidence indicates that overexpression of GABAAR alone in non-neuronal cells (lacking 
collybistin and presumably gephyrin) is sufficient to generate functional contacts, generating 
inhibitory postsynaptic currents (Fuchs et al., 2013). 
Functional regulation of GABAA receptor subtypes: significance for GABAergic synapse 
plasticity 
GABAARs are regulated by ubiquitous transcriptional and post-translational processes, as well as by 
multiple protein-protein interactions. As discussed above with regards to their interactions with 
gephyrin, there is considerable subtype specificity in the regulation of GABAARs, which allows 
neurons expressing several receptor subtypes to make fine, synapse-specific adjustments in response 
to a large array of extrinsic and intrinsic signals. Here, we will discuss the regulation of GABAAR 
subtypes in mature neurons, focusing on four major aspects: 
Transcriptional control of GABAA receptor subunit expression: The gene structure and chromosomal 
localization of human (and rodent) GABAARs are well established (Simon et al., 2004), and their 
promoter sequences and binding sites for transcription factors and regulatory elements subject to 
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intense scrutiny (reviewed in (Steiger & Russek, 2004)). Still, little is known how the subunit 
repertoire of any given neuron is determined during development, although models explaining the 
coordinated expression of subunits located in gene clusters (e.g., 2-1-2-6) have been proposed 
(Uusi-Oukari et al., 2000; Joyce, 2007). A remarkable variability in the abundance of mRNAs 
encoding the 19 GABAAR subunits has been uncovered in both mice and human, with considerable 
regional specificity, and being under the control of multiple gene regulatory mechanisms (Mulligan et 
al., 2012). In addition, there is strong evidence for transcriptional regulation of GABAAR subunits by 
neurosteroids, as well as in a number of pathological conditions, including epilepsy, ethanol 
intoxication, Alzheimer’s disease, and schizophrenia (reviewed in (Steiger & Russek, 2004; 
Grabenstatter et al., 2012)). A recent genetic study identified a chromosomal duplication in a locus 
encoding four GABAAR subunits (4p12; 2, 4, 1, 1) associated with neurodevelopmental 
disorders (Polan et al., 2013). In contrast, it is not well established whether the compensatory increase 
in subunit expression observed in some GABAAR subunit KO mice (see Box 1) reflects transcriptional 
control or is due to changes in mRNA stability and/or by post-translational mechanisms (Peng et al., 
2002; Kralic et al., 2006; Ogris et al., 2006). The issue is of relevance, because these compensatory 
changes contribute to maintain homeostatic balance between excitation and inhibition in the mutant 
mice. Transcriptional control of GABAAR subunit expression would probably involve activity-
dependent mechanisms targeting specific transcription factors (or possible non-coding RNAs), and 
would need to deal with the regulation of local translation in dendrites (Cajigas et al., 2012).  
Posttranslational modifications of GABAA receptors: Membrane-anchoring of GABAARs is 
regulated by palmitoylation of the 2 subunit and this mechanism contributes to normal formation and 
function of GABAergic synapses (Fang et al., 2006). In addition, it is well established that multiple 
phosphorylation mechanisms, targeting various GABAAR subunits, play a key role in modulating the 
efficacy of GABAergic transmission, either by changing single-channel gating or kinetic properties, or 
by regulating stability, cell-surface delivery, or internalization of GABAARs (reviewed in (Jacob et al., 
2008; Houston et al., 2009; Luscher et al., 2011a; Vithlani et al., 2011)). Combined with recent 
reports that gephyrin phosphorylation at residues S268 and S270 by GSK3 and ERK, respectively, is 
a negative regulator of GABAergic transmission (Tyagarajan et al., 2011b; Rui et al., 2013; 
Tyagarajan et al., 2013), these data indicate that multiple signaling pathways can dynamically 
modulate neuronal excitability by activating protein kinases or phosphatases, as well as their 
downstream effectors. As phosphorylation events on GABAARs are subunit-specific, differential 
effects can be expected for various GABAAR subtypes, even within the same neuron. Furthermore, 
considering the tight functional coupling between the gephyrin scaffold and postsynaptic GABAARs, 
the question arises whether phosphorylation of gephyrin and GABAARs is coordinated. As gephyrin 
carries multiple consensus sites for phosphorylation (and other post-translational modifications, such 
as acetylation and SUMOylation) (Tyagarajan & Fritschy, 2014), the response to this question awaits 
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their further characterization. In addition, it is conceivable that the gephyrin scaffold serves to anchor 
protein kinases (and phosphatases) acting on GABAARs and therefore regulates the efficacy of 
receptor posttranslational modifications. 
A major advance in our understanding of the in vivo significance of GABAAR phosphorylation is 
provided by the generation of knock-in mice carrying point-mutations that abolish phosphorylation of 
residues known to be targeted by protein kinases in vitro. However, these studies have unraveled 
unexpectedly strong effects of the mutations, with 2(Y365/367F) mutation being embryonically 
lethal, and inducing in heterozygous mice sex-specific increased in tonic inhibition (4/-GABARs) 
to compensate for reduced neurosteroid sensitivity in the thalamus (Jurd & Moss, 2010; Nani et al., 
2013). 
Regulation of GABAA receptor trafficking and cell-surface diffusion: Membrane insertion (and 
internalization) of GABAARs occurs at extrasynaptic sites, followed by lateral diffusion and reversible 
trapping in the postsynaptic membrane (Bogdanov et al., 2006), suggesting dynamic regulation of 
phasic inhibition from a reserve pool of extrasynaptic receptors (Thomas et al., 2005). Furthermore, 
preventing docking of GABAARs at endocytotic zones in the plasma membrane  by interfering with a 
binding motif located in the intracellular loop of the 3 subunit  blocked GABAAR internalization, as 
well as down-regulation following oxygen-glucose deprivation, a model of ischemia in vitro (Smith et 
al., 2012). Such observations underscore that regulated diffusion of GABAARs in the plasma 
membrane is of prime relevance under physiological and pathophysiological conditions.  
Single-particle tracking studies also revealed that GABAAR mobility at the cell surface and at 
postsynaptic sites is tightly regulated by activity-dependent mechanisms and differential interactions 
with gephyrin (Bannai et al., 2009; Shrivastava et al., 2011; Niwa et al., 2012). Thus, postsynaptic and 
extrasynaptic GABAARs have similar diffusion rates in the plasma membrane, but the former remain 
confined longer in GABAergic postsynaptic sites and their trapping depended of presence of the 
gephyrin scaffold (Mukherjee et al., 2011; Renner et al., 2012). Increasing synaptic activity, leading to 
Ca
2+
 influx, reduced the amplitude of mIPSCs, due to dispersion of GABAAR to extrasynaptic sites by 
a mechanism involving the protein phosphatase calcineurin (Bannai et al., 2009). Recent evidence 
indicates, however, that this activity-dependent Ca
2+
 influx also affects the gephyrin scaffold, although 
dispersion of GABAARs and gephyrin occur with different time scales, partially independently of each 
other (Niwa et al., 2012). Taken together with previous evidence (Muir et al., 2010), these results 
indicate that cross-talk between excitatory and inhibitory transmission occurs via the activation of 
Ca
2+
-dependent signaling events that impinge on both GABAARs and the postsynaptic scaffold. Much 
remains to be determined how these phenomena observed in vitro are mediated in vivo, and whether 
they selectively affect specific GABAAR subtypes in cortical principal cells or cause global effects 
across various types of synapses. 
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Regulation of GABAAR-mediated transmission by neurotrophins and metabolic factors: 
Neurotrophins, such as BDNF, have major effects on excitatory synaptic plasticity, mediated by 
multiple signaling pathways downstream of TrkB. It is, therefore, no surprise that BDNF also 
regulates the strength of GABAAR-mediated transmission, by acting on both GABAergic synapse 
formation (Chen et al., 2011) and plasticity: BDNF produces bi-phasic effects on GABAAR-mediated 
transmission, reflecting its action on cell surface expression (Brünig et al., 2001; Jovanovic et al., 
2004). In a recent study, the possibility has been raised that BDNF acutely causes internalization of 
1-GABAARs in the amygdala by causing rapid gephyrin degradation (Mou et al., 2013). However, a 
long-lasting enhancement of GABAAR-mediated transmission in the hippocampus, due to enhanced 
cell surface expression, has been shown to arise from phosphorylation of the tyrosine residues Y657 
and Y367 in the 2 subunit (Vithlani et al., 2013); the significance of this modulation, as tested in 
2(Y365/367F) knock-in mice, is anti-depressant behavioral phenotype and increased hippocampal 
neurogenesis, raising the possibility that GABAAR phosphorylation regulates the anti-depressant 
action of BDNF.  
We have recently uncovered a novel mode of GABAAR regulation, activated by reactive oxygen 
species (ROS) and, therefore, by cellular metabolism (Accardi et al., 2014). In this study, blocking the 
mitochondrial respiratory chain, or elevating intracellular ROS in cerebellar interneurons, caused a 
gradual increase in the frequency of mIPSCs, due to the appearance of additional low amplitude 
currents with slow decay kinetics. While the majority of mIPSCs in these cells are mediated by 1-
GABAARs, these newly induced currents had kinetic properties of 3-GABAARs, and, indeed, 
depended on expression of the 3 subunit in these cells, as tested in 3-KO mice (whereas deletion of 
the 1 subunit had no effect on this phenomenon). Along with evidence that the effects of ROS 
elevation are due to postsynaptic adaptations, rather than presynaptic changes in transmitter release, 
these results suggested that ROS activate a signaling cascade leading to the selective recruitment of 
3-GABAAR to either “silent” synapses, or to de novo formed synaptic contacts from terminals known 
to form multiple release sites (Accardi et al., 2014). In line with these results, insulin acutely increases 
GABAAR cell-surface expression in vitro (Wan et al., 1997), but it is not established whether the same 
mechanism is involved. 
Significance for GABAergic synapse plasticity: The main conclusion derived from studies of 
GABAAR (and gephyrin) post-translational regulation is that GABAergic synapses represent dynamic 
entities regulated by multiple mechanisms to homeostatically adjust the responsiveness and function of 
neuronal networks to changes in their environment. These regulatory adjustments concern both post- 
and extrasynaptic receptors and involve multiple intracellular signaling cascades. We have speculated 
elsewhere that by means of its role as scaffolding protein, gephyrin might interact with various 
effectors to adjust the structure and function of GABAergic synapses over a considerable dynamic 
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activity range (Tyagarajan & Fritschy, 2014); thereby ensuring homeostatic synaptic plasticity in 
mature neuronal circuits.  
Posttranslational regulation of GABAARs (and gephyrin) is implicated in functional plasticity of 
GABAergic synapses, as demonstrated in several systems (reviewed in (Kullmann et al., 2012). For 
example, a well-studied model is rebound potentiation at inhibitory synapses of cerebellar Purkinje 
cells, which is induced by depolarization of Purkinje cells and involves Ca
2+
 influx and activation of 
calcium-calmodulin kinase 2 (Kano et al., 1996). Rebound potentiation involves trafficking of 
GABAARs to enhance their surface expression, and is necessary for adaptation of the vestibule-ocular 
reflex, a form of Purkinje cell-dependent motor learning (Kawaguchi & Hirano, 2007; Tanaka et al., 
2013). In addition to functional plasticity, regulation of GABAARs also contributes to structural 
plasticity by inducing changes in GABAergic synaptic connectivity. For example, chronic treatment of 
Ts65Dn mouse mutants, a model of Down syndrome, with a selective 5-GABAAR negative allosteric 
modulator reduced the density of GABAergic synapses in the hippocampal formation and normalized 
behavior in these mutants (Martínez-Cué et al., 2013). 
GABAA receptor heterogeneity in times of change: CNS development and adult 
neurogenesis 
Developmental changes in GABAA receptor subunit expression: GABAARs are expressed at early 
stages of fetal brain development by neural precursor cells and during neuronal differentiation, and 
have been proposed to regulate cell proliferation, migration, and differentiation, possibly through 
Ca
2+
-mediated signals activated by neuronal depolarization (reviewed in (Represa & Ben-Ari, 2005; 
Cellot & Cherubini, 2013; Lu et al., 2013)) (see box 4). Accordingly, one might expect developmental 
deficits in the CNS of GABAAR subunit knock-out mice, notably with regard to subunits highly 
expressed in fetal brain. However, among the targeted deletions analyzed so far (1-6, 2, 3, , 2) 
no detectable alterations in brain general architecture at birth have been reported, suggesting the 
existence of compensatory mechanisms substituting for the missing receptor subtype. Therefore, the 
absence of phenotype in these mutant mice should not be taken as evidence that GABAARs are 
dispensable for regulating brain development. Rather, they might be so important that functional 
redundancy has been developed to prevent deleterious effects in case of dysfunction of a given 
subtype. 
******************************* 
* Box 4 approximately here * 
******************************* 
It is well established that the subunit composition of predominant GABAAR subtypes changes during 
the period of synaptogenesis, accounting in part for the distinct functional and pharmacological 
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properties of GABAARs in neonatal and mature brain (Fritschy et al., 1994; Paysan et al., 1997; 
Hutcheon et al., 2000; Bosman et al., 2002; Fagiolini et al., 2004; Peden et al., 2008; Hashimoto et al., 
2009). Nevertheless, there is only fragmentary information about the expression pattern of GABAAR 
subunits in neural precursor cells and immature neurons. mRNA in situ hybridization data available in 
the Allen Brain Atlas  (http://mouse.brain-map.org) show predominance of 2, 3, 5, 2, 3, 2 
subunits at E18.5. As this stage precedes synaptogenesis, one might assume that these receptors are 
mainly engaged in tonic, possibly depolarizing, GABAergic transmission. In particular, the 5 subunit 
is strongly expressed perinatally and decreases during synaptogenesis, except in regions where it 
remains abundant in adult brain (hippocampal formation, olfactory bulb, brainstem). Of note, down-
regulation of the 5 subunit in layer 4 of the neocortex and its replacement by the 1 subunit, have 
been shown to be dependent on the integrity of thalamocortical projection (Paysan et al., 1997), 
providing an attractive model to study the mechanisms underlying (post-)transcriptional control of 
subunit expression. In contrast to 5, other subunits defining the main extrasynaptic GABAARs of the 
adult brain (4, 6, ) are absent or expressed at low levels in fetal brain, and are upregulated when 
neuronal maturation nears completion. In human neocortex, the GABAergic system develops during 
the second half of pregnancy and infancy (Xu et al., 2011), and the expression of GABAAR subunit 
genes appears to be coordinated based on their respective chromosomal localization (Fillman et al., 
2010), with distinct up- and down regulation patterns suggestive of differential expression of specific 
GABAAR subtypes. 
To elucidate why the pattern of GABAAR subunit expression evolves during ontogeny, considerable 
attention was given to 1-GABAARs, which are upregulated in a region-specific manner during the 
phase of synaptogenesis to become the predominant GABAAR subtype present in adult CNS (Fritschy 
et al., 1994; Paysan et al., 1994; Hashimoto et al., 2009). As these receptors typically display fast 
decay kinetics and generate large amplitude events (Eyre et al., 2012), their gradual appearance was 
taken as evidence for a maturation of GABAergic function (Vicini et al., 2001; Bosman et al., 2002); 
in particular to endow postsynaptic neurons with fast acting receptors matching the high firing rate of 
certain interneurons. Furthermore, as discussed in the next paragraph, 1-GABAARs on perisomatic 
synapses of cortical pyramidal cells enable critical windows of plasticity (Fagiolini et al., 2004). 
Similar, but reversible, changes in subunit expression have been proposed to account for plasticity of 
GABAergic transmission in the supraoptic nucleus during gestation and after delivery (Brussaard et 
al., 1997). However, there is evidence from several electrophysiological studies that the acceleration 
of mIPSC kinetics occurring during brain development or following hormonal fluctuations do not 
depend solely on the subunit composition of GABAARs (Koksma et al., 2003; Koksma et al., 2005; 
Peden et al., 2008). Rather, post-translational modifications mechanisms affecting GABAAR gating 
properties, and possibly their trafficking and interactions with scaffolding proteins, might also play a 
role in defining their gating properties. 
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To fully understand how differential expression of GABAARs shapes the functional properties of 
GABAergic transmission, it will be essential to determine, as well, the developmental GABAAR 
expression profile in interneurons, as these receptors will have a key role on the maturation and 
determine the firing properties of input cells controlling synaptic circuits.  
GABAA receptor subtype setting critical periods of plasticity: The seminal observation that the time 
of opening of critical period windows (during which sensory deprivation causes lasting structural and 
functional alterations) can be delayed or advanced by reducing or enhancing GABAergic transmission 
provided direct evidence for the fundamental role played by GABAAR-mediated transmission in 
regulating cortical development (Hensch et al., 1998; Fagiolini & Hensch, 2000). Further 
investigations unambiguously showed that this effect requires a highly specific cortical circuit 
(Katagiri et al., 2007), involving a central role for large parvalbumin-positive basket cells, which 
control the output of principal cells by activating 1-GABAARs (reviewed in (Hensch, 2005)). The 
latter piece of the puzzle was brought about by the demonstration that diazepam is unable to advance 
the opening of a critical period window in 1(H101R) mice (Fagiolini et al., 2004). 
GABA is not the only neurotransmitter involved in this process, as modulation of nicotinic 
acetylcholine receptors by targeted deletion of Lynx1, a membrane-anchored prototoxin that 
negatively regulates nicotinic acetylcholine receptor function (Ibañez-Tallon et al., 2002), allows re-
opening of critical period windows in adulthood; remarkably, this effect of Lynx1 deletion can be 
blocked by co-application of diazepam, demonstrating that a balance between excitation and 
inhibition, rather than the action of a single transmitter, is determinant for setting the opening and 
closing of critical period windows (Morishita et al., 2010).  
The relevance of parvalbumin-positive basket cells for setting network configurations permissive for 
structural and functional plasticity, required for learning and memory acquisition, is not restricted to 
critical period windows, but appears to be a fundamental principle of brain plasticity (Donato et al., 
2013), involving a canonical pattern of interconnections between interneurons (Pfeffer et al., 2013). 
According to these experiments, inhibitory control of parvalbumin-positive basket cells by VIP-
positive interneurons is low in mice exposed to conditions permissive for learning (e.g., enriched 
environment) and high, either when a new task is acquired or when adverse conditions (e.g., fear 
conditioning) lead to memory retention. Remarkably, maturation and strength of inhibitory control of 
parvalbumin-positive basket cells is regulated by the transcription factor Otx2. This secreted molecule 
requires binding to a specific receptor in perineuronal nets – which selectively surround parvalbumin-
positive interneurons – for cell penetration and activation of gene transcription (Beurdeley et al., 
2012). 
Taken together, these results underscore the fact that GABAergic transmission in developing brain 
(and during permissive phases of plasticity critical for learning and circuit refinement) is regulated by 
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sophisticated mechanisms, and mediated by specific circuits containing defined GABAAR subtypes, 
such as 1-GABAARs in synapses formed on principal cells by parvalbumin-positive basket cells. 
Regulation of adult neurogenesis: In analogy to brain development, GABAARs expressed by stem 
cells, neural precursor cells and immature neurons contribute to proliferation, migration, 
differentiation and synaptic integration of adult-born neurons (reviewed by (Overstreet et al., 2005; Ge 
et al., 2007; Sernagor et al., 2010; Nissant & Pallotto, 2011)). Likewise, as in developing neurons, 
GABA initially exerts depolarizing effects on precursor cells (see Box 4), activating Ca
2+
-dependent 
mechanisms that have enduring effects on precursor cell migration, cell survival, and subsequent 
neuronal maturation (Overstreet et al., 2005; Ge et al., 2006; Jagasia et al., 2009; Chancey et al., 
2013).  
Adult neurogenesis, taking place in the subventricular zone of the lateral ventricles and in the 
subgranular zone of the dentate gyrus, represents an important facet of brain plasticity regulated by 
GABAergic mechanisms. Experimentally, it offers an attractive paradigm for investigating the role of 
GABAAR-mediated regulation of neuronal maturation and functional integration into pre‐existing 
synaptic circuits. Thus, analyzing the consequences of GABAAR inactivation in radial glia-like stem 
cells revealed that local parvalbumin-positive fast-spiking interneurons in the dentate gyrus determine 
their mode of division (symmetric versus asymmetric) as well as neuronal versus glial fate (Song et 
al., 2012); furthermore, the pharmacological profile of these receptors (zolpidem-insensitive) is 
compatible with expression of 5-GABAAR in these stem cells. Along the same line, investigating the 
role of extrasynaptic (4, ) and postsynaptic (2) GABAARs inactivated by gene targeting, we have 
provided evidence that these GABAAR subtypes regulate distinct phases of adult neurogenesis in the 
dentate gyrus (Duveau et al., 2011). In line with findings that GABA exerts a negative control on 
neural precursor cell proliferation (Platel et al., 2007), 4-KO mice exhibited increased neurogenesis. 
No phenotype was seen in -KO mice, as expected from the delayed expression of this subunit during 
ontogeny (but see (Whissell et al., 2013)). Ablation of 4-GABAARs also impaired dendritic growth 
and final positioning of adult-born granule cells; in contrast, 2-KO newborn neurons exhibited 
delayed pruning of dendritic branches, presumably to maintain inhibitory-excitatory balance upon 
maturation of glutamatergic inputs (Duveau et al., 2011).  
A more dramatic phenotype was observed upon selective 2 subunit inactivation in adult-born 
olfactory bulb granule cells (Pallotto et al., 2012), which represent the main interneuron subtype of the 
olfactory bulb, continuously generated from mitotic precursor cells in the subventricular zone 
(Carleton et al., 2003). As 2-GABAARs provide most synaptic inhibition to these cells, their 
inactivation profoundly altered dendritic development, spine formation, and maturation of 
glutamatergic inputs. Also, modulation of dendritic differentiation by environmental enrichment or 
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deprivation, which is prominent in wildtype adult-born granule cells (Saghatelyan et al., 2005), was 
abrogated in adult-born 2-KO granule cells (Pallotto et al., 2012). The severity of these effects 
underscores the central role played by GABAAR in regulating neuronal differentiation. Moreover, 
these results taken together provide an exquisite demonstration that GABAAR subtypes are specialized 
to fulfill specific tasks, with considerable spatio-temporal specificity. 
Significance for CNS disorders 
Elucidation of the molecular organization and regulation of GABAAR subtypes opens new 
perspectives for understanding pathophysiological mechanisms in neurological and psychiatric 
diseases and for developing treatment approaches that go beyond symptomatic relief. Key aspects of 
the possible involvement of GABAAR-mediated transmission in the pathophysiology of CNS disorders 
lie in their contribution to developmental processes and dependence on Cl

 and HCO3

 fluxes (see Box 
4). In turn, GABAAR dysfunction can be determined genetically, and/or depend on abnormal 
regulation and trafficking. Here, we briefly discuss these mechanisms at the light of a few selected 
examples. 
GABAAR subunit mutations are typically associated with generalized, mostly idiopathic epilepsies and 
Dravet syndrome. They have been described in  subunits, 3, as well as 2 and . While data are 
somewhat controversial, the majority of these mutations impair trafficking and cell surface expression 
of GABAARs, as well as their diffusion dynamics in the plasma membrane (hence, their postsynaptic 
clustering (Bouthour et al., 2012)) (reviewed in (Galanopoulou, 2010; Macdonald et al., 2010). Some 
of these effects have been proposed to be temperature-dependent, hence providing a plausible cause 
for febrile seizures. However, the general picture emerging from these studies is that there is that 
GABAAR mutations cause multiple molecular and biochemical alterations, which are not easily related 
to specific symptoms of disease, notably epileptogenesis and seizure occurrence; thereby reflecting the 
complexity of mechanisms underlying epileptic syndromes. 
GABAAR mutations have also been associated with other CNS pathologies. For example, although the 
complex interactions between ethanol intoxication or ethanol dependence and GABAARs go beyond 
the scope of this review, it is worth mentioning that a  dominant point-mutation in the 1 subunit 
(L285R), which causes spontaneous channel openings and strongly enhances tonic inhibition in the 
nucleus accumbens, was shown recently to induce severe spontaneous ethanol consumption in mice 
(Anstee et al., 2013). In the same study, the selective contribution of 1-containing GABAAR was 
confirmed by a second mutation, which caused similar behavioral phenotype. These data underscore 
the main contention of this review, namely how dysfunction of specific GABAAR subtypes, affecting a 
minor subpopulation of receptors, can cause strong behaviorally relevant effects. 
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Brain lesions, such as stroke or temporal lobe epilepsy with hippocampal sclerosis, lead to 
pathological alterations in GABAergic tonic inhibition, due to over-expression or reduction of specific 
GABAAR subtypes (reviewed in (Hines et al., 2011; Grabenstatter et al., 2012; Houser et al., 2012)). 
In a seminal report investigating the relevance of tonic inhibition in stroke, Clarkson et al showed that 
reducing tonic inhibition in the peri-infarct area, a zone that is of crucial importance for functional 
recovery, with infusion of a benzodiazepine inverse agonist, or by genetically reducing expression of 
extrasynaptic GABAARs, promoted functional recovery (Clarkson et al., 2010). These data go well in 
line with evidence that GABAergic transmission regulates neuronal plasticity by setting inhibitory-
excitatory balance in neuronal networks. 
GABAAR-mediated transmission during brain development has been linked to the emergence of 
neurodevelopmental disorders, as well as adult-onset diseases that depend on proper formation of 
neuronal circuits, such as schizophrenia and depression (Luscher et al., 2011b; Lewis, 2012; Marín, 
2012). Similarly, abnormal GABAergic transmission during critical periods of development can cause 
severe sensory deficits, such as amblyopia, as well as impair sensory-motor and cognitive 
development; importantly, understanding the underlying mechanisms provides cues for therapeutic 
intervention (Bavelier et al., 2010). Table 1 lists four principal mechanisms through which altered 
GABAergic transmission during CNS development and maturation has been implicated in brain 
diseases. In most cases, alterations can be traced back to mutations affecting neuronal maturation, 
synapse formation, and/or signaling cascades. As GABAAR-mediated transmission and inhibitory-
excitatory balance regulates key steps of neuronal migration and differentiation, the effects can be 
enduring. Thus, conditional inactivation of one 2 subunit allele at defined stages of brain maturation 
induces either depression-like or anxiety-like behaviors in adult mice (Shen et al., 2012). While the 
underlying mechanisms are not yet fully elucidated, they comprise alteration of adult neurogenesis in 
the dentate gyrus, as well as changes in synaptic connectivity and function of specific interneurons, 
notably fast-spiking parvalbumin-positive basket cells and somatostatin-positive interneurons. The 
crucial role played by interneurons for proper development of GABAergic synaptic connections is 
underscored by the long-ranging consequences of cell type-specific conditional gene deletions, such as 
inactivation of ErbB4 in parvalbumin-positive cortical interneurons, which affects formation of axo-
axonic synapses and synchronization between prefrontal cortex and hippocampal formation, leading to 
schizophrenia-like phenotype (Del Pino et al., 2013). In human, a corresponding deficit in axo-axonic 
synapses in prefrontal cortex is selectively found in schizophrenia but not bipolar disorder, and is 
accompanied by compensatory upregulation of the 2 subunit in the axon initial segment of pyramidal 
cells (reviewed in (Lewis & Hashimoto, 2007)). 
The analysis of knock-in mice expressing diazepam-insensitive GABAAR subtypes (see Box 2) has 
noticeably expanded the catalogue of potential therapeutic applications of benzodiazepine site-ligands, 
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provided that subtype-specificity and differential efficacy can be achieved with novel compounds 
(reviewed in (Rudolph & Möhler, 2013)). These studies also implicate potential dysfunction of 
GABAARs in a broader set of diseases than those treated with classical benzodiazepine site-ligands. 
Thus, 2-GABAARs not only mediate diazepam anxiolysis, but they contribute to anxiety-related 
behaviors elicited by exposure to novelty and mild threat, as shown in 2-KO mice (Koester et al., 
2013). These receptors also contribute to mood disorders and chronic pain, and polymorphisms in 
GABRA2 have been linked to alcohol dependence and drug abuse (Engin et al., 2012). In chronic pain, 
the anti-hyperalgesic action of benzodiazepine site ligands devoid of sedative liability occurs primarily 
via stimulation of 2-GABAARs in primary afferents and in the spinal cord dorsal horn, without 
involving supra-spinal sites (Witschi et al., 2011; Paul et al., 2013). 5-GABAARs, as noted in Box 3, 
regulate learning and memory, as well as hippocampal neurogenesis, and represent a promising target 
for improving cognitive performance in Down syndrome patients. These receptors also have been 
implicated in memory deficits associated with acute neuroinflammation, possibly because interleukin 
1 increases their cell surface expression in hippocampal neurons (Wang et al., 2012). Considering the 
multiple post-translational mechanisms regulating GABAAR-mediated transmission, the latter finding 
opens the possibility that multiple chemokines and cytokines might affect GABAergic transmission by 
activating the underlying signaling pathways. Therefore, one might speculate that GABAARs 
contribute extensively to the mediation of neuro-immune interactions. 
Conclusions and perspectives 
This review discusses the evidence that GABAARs form multiple subtypes, endowed with specific 
functional and pharmacological properties and being differentially regulated by multiple mechanisms, 
at the level of both gene expression and protein modification. Furthermore, we underscore that this 
regulation does not operate in isolation, but is intimately linked to the regulation of the postsynaptic 
scaffold organized by gephyrin, thereby vastly enlarging the repertoire of mechanisms that 
dynamically contribute to fine-tuning GABAergic transmission in response to various extracellular 
and intracellular signals. From this perspective, GABAAR-mediated transmission appears as a multi-
facetted process fundamental to proper brain development, function, and plasticity. The analysis of the 
specific role of GABAAR subtypes reveals their implication in the pathophysiology of major CNS 
disorders and open novel perspectives for therapeutic intervention; notably based on subtype-specific 
ligands, and/or targeting specific signaling pathways regulating GABAergic synapse function. 
While the concept of GABAAR subtype, with well-defined subunit composition and functional 
properties, holds well in the adult brain, it is more difficult to define (and test) during brain 
development, when synaptic transmission is not yet present, and most effects of GABA are mediated 
by auto- or paracrine mechanisms. In particular, there are no behavioral readouts to probe the 
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consequences of altered GABAAR function in developing animals, and the significance of the major 
changes in subunit expression taking place during synaptogenesis remains unexplored. Nevertheless, 
the evidence available, in particular from studies of critical window plasticity and of adult 
neurogenesis (during which developmental processes are re-initiated in adult brain) provides strong 
support to the contention that GABAAR subtypes are tailor-made to modulate highly specific steps of 
neuronal differentiation and circuit formation during CNS ontogeny.  
Several GABAAR subtypes, encoded by “rare” subunits (1, 3, , , ), remain to be characterized. 
Their restricted localization in specific brain regions (notably hypothalamus and basal forebrain), 
coupled with a non-conventional pharmacological profile, offer opportunities for selective intervention 
to regulate specific brain functions, notably related to the neuro-endocrine axis, sleep-wake regulation, 
and central autonomic function. However, these distant perspectives will first require the development 
of analytical tools (and genetically engineered mice) to probe the function of these so far overlooked 
GABAAR subtypes. 
The major focus given recently to “extrasynaptic” receptors, notably those containing the  subunit, 
follows the same logic to exploit receptors possessing non-conventional pharmacological profile and 
unique regulatory mechanisms for improved therapeutic intervention. These perspectives are broad, 
ranging from stress-related disabilities to the treatment of stroke, epilepsy, alcohol intoxication, and 
drug dependency. However, much remains to be learned how these receptors are regulated and how 
they interact with membrane-proteins and intracellular effectors. The other major population of 
extrasynaptic GABAARs, containing the 5 subunit, also offers promising perspectives as a target for 
improving intellectual disabilities, memory functions, and cognition. However, as seen with the 
analysis of 5(H105R) mutant mice (see Box 3), care has to be taken in the interpretation of 
behavioral performance in mice.  
The molecular heterogeneity of GABAAR subtypes provides the substrate for differential 
transcriptional and translational regulation. Much remains to be learned how post-translational 
regulation impacts on trafficking and function of specific receptor subtypes, as well as how the 
presence/absence of a defined subunit changes this regulation. One might speculate, for example, that 
the heterogeneity of   subunits, which are associated with multiple  subunits,  adds to the regulation 
of GABAAR function, because the  subunits are differentially targeted by protein kinases and 
phosphatases (Houston et al., 2008). In contrast, phosphorylation of the 2 subunit might represent a 
mechanism common to multiple GABAAR subtypes. Our recent observation that 3-, but not 1-
GABAARs, are selectively targeted to postsynaptic sites to enhance GABAergic transmission when 
intracellular levels of ROS are increased (Accardi et al., 2014) provides a striking example for a 
GABAAR subtype-specific regulation to adjust the strength of inhibition in response to a specific 
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stimulus. Uncovering the underlying mechanisms of this specific adaptation will help understanding 
the difference between 3- versus 1-GABAARs. Furthermore, considering that 1-, 2, and 3-
GABAARs comprise the vast majority of postsynaptic GABAARs, it will be essential to unravel their 
distinguishing features, which require them to be differentially expressed and targeted to distinct 
subcellular sites. As a first step towards this goal, a proteomics analysis of GABAergic PSDs, and/or 
the characterization of the interactome of each main GABAAR subtype, would provide an exhaustive 
list of signaling pathways involved in their trafficking and synaptic function. 
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Box 1: Limitations of immunohistochemistry for studying GABAA receptors  
Whereas GABAAR are pentameric protein complexes, immunohistochemistry only allows the 
visualization of individual subunits, each of which belongs to several subtypes. Furthermore, as the 
pentamer contains 2 and 2 subunits, it is not possible in neurons expressing multiple  or  subunit 
variants to determine whether they belong to the same receptor, or to distinct receptors with similar 
subcellular distribution. Therefore, the exact GABAAR subtype repertoire of any neuron type is not 
established (see, for example, (Panzanelli et al., 2011)). A further limitation is that, so far, there are no 
antibodies suitable for immunochemistry for some of the GABAAR subunits. In particular, very little 
information is available for the distribution of the 1, 3, , , and  subunit proteins, as well as 1-3 
subunits, either at a regional, cellular, or subcellular level. As a result, several GABAAR subtypes, 
probably with atypical pharmacology and a highly selective distribution, remain poorly characterized 
and their contribution to inhibitory transmission in these specific CNS areas is unknown.  
Besides these limitations, it should be emphasized that although immunohistochemistry reveals the 
detailed distribution and relative staining intensity of each subunit across the CNS, this method does 
not allow quantitative comparisons between antibodies (and thus assessing the abundance of a given 
subunit relative to other subunits), because the affinity of antibodies to their epitope, and its 
accessibility in tissue sections prepared for histology, cannot be directly measured. Furthermore, in the 
light of evidence showing that the specificity and sensitivity of the immunohistochemical procedure 
critically depends on epitope accessibility (Lorincz & Nusser, 2008), each antibody should be tested 
with various antigen retrieval methods. This is particularly important to interpret lack of staining for a 
specific antibody in some regions and to accurately determine the subcellular distribution of GABAARs. 
This latter point is of crucial relevance for understanding the functional organization of the GABAergic 
system. Functional and biochemical studies differentiate among several pools of GABAARs in neurons, 
being localized intracellularly (reflecting biosynthesis, metabolism, reserve pool) or at the cell surface, 
post- or extrasynaptically (see Box 3). Immunohistochemical studies have shown that the detection of 
postsynaptic GABAARs is largely impaired by aldehyde fixation and requires alternative methods to the 
classical transcardial perfusion. Therefore, immunohistochemical analysis of GABAAR subunit 
distribution provides distinct results depending on the fixation method used. Furthermore, we had 
noted in our initial report (Fritschy & Mohler, 1995) that the cellular distribution pattern of GABAAR 
revealed by each antibody across brain regions is highly variable, ranging from diffuse staining of the 
neuropil to “Golgi-like” staining of a few neurons, outlining their entire dendritic tree. This feature 
makes it impossible to quantify with a single densitometric parameter the abundance of a subunit in a 
given brain region, as it can be widely different for various cell types. 
Therefore, analyses of regional distribution patterns, showing marked differences in subunit 
abundance across different anatomical structures of the CNS, need to be complemented with methods 
allowing cellular and subcellular resolution to map GABAAR subtypes in a synapse-specific manner, 
and to derive some quantitative measurement of relative receptor abundance. We have recently 
reported a method allowing concurrent visualization of postsynaptic GABAARs with high sensitivity and 
resolution and biochemical analysis using brain tissue from the same animal (Notter et al., 2013). In 
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the future, new methods will have to be devised to unequivocally detect pre-synaptic GABAARs, 
whose existence is well established functionally, but whose distribution in axons remains largely 
elusive. 
The limitations of immunohistochemistry are even more evident for ultrastructural studies, in which the 
sensitivity of the method is reduced by the strong fixation required for ultrastructural preservation. It 
was recognized early on that pre-embedding immune-electron microscopy is not suitable for the 
detection of GABAARs at postsynaptic sites (Somogyi et al., 1989). Post-embedding techniques, 
notably following tissue embedding in Lowicryl permitted to circumvent this problem, but have low 
sensitivity and have been successful with only a limited number of subunits (Nusser et al., 1995; 
Somogyi et al., 1996; Panzanelli et al., 2004). More recently, the development of SDS-digestion after 
freeze-fracture has enabled substantial progress by allowing the 3-D visualization and quantification of 
GABAARs in the plasma membrane (Kasugai et al., 2010), albeit working only with a limited number of 
antibodies. 
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Box 2: Lessons from Gabra knock-out and knock-in mice: GABAA receptor subtypes fulfill 
specific tasks  
Targeted deletion of a GABAAR subunit gene, especially when constitutive, can lead to important 
changes in the distribution and expression pattern of the remaining subunits, suggestive of 
compensatory adaptations. For example, Gabra1 knock-out (1-KO) mice exhibit upregulation of 2- 
and 3-GABAARs in regions where the 1 subunit is abundant (Kralic et al., 2006; Zeller et al., 2008); 
-KO mice exhibit increased 4 subunit expression, associated with the 2 subunit, and with altered 
subcellular distribution (Peng et al., 2002). Typically, however, the receptor subtype that is missing as 
a consequence of the deletion is not merely “replaced” by another subtype present in the same cell. 
This feature is particularly striking in neurons expressing a mixture of postsynaptic and extrasynaptic 
receptors. Deletion of the  subunit variant present in the postsynaptic receptors leads to their 
disappearance (and corresponding loss of postsynaptic currents), whereas the extrasynaptic receptors 
remain either unchanged, or increased (Kralic et al., 2006; Peden et al., 2008). Therefore, the inability 
of 4-GABAARs to cluster at postsynaptic sites is not due to competition with other receptor subtypes. 
In neurons expressing multiple postsynaptic receptors, synapse-specific rearrangements occur, but 
there is no replacement of the missing receptor, as seen, for example, in CA1 pyramidal cells of 2-
KO mice, where 1-GABAARs remain unaffected in perisomatic synapses, but disappear from the 
axon initial segment (Panzanelli et al., 2011). Some striking forms of compensation have been 
reported, which remain unexplained. Thus, in thalamic reticular neurons of 3-KO mice, 
immunohistochemistry reveals apparent loss of postsynaptic GABAARs and gephyrin, but these 
mutants exhibit larger postsynaptic currents than wildtype mice (Schofield et al., 2009). 
These observations lend to the contention that GABAAR subtypes, defined by their subunit 
composition, are unique functional entities, fulfilling specific tasks, without being inter-changeable 
within a given type of neuron. This contention received further support from the analysis of (H101R) 
knock-in mice, engineered to remove the diazepam binding site located at the / interface of the 
pentameric complex, without affecting assembly, cell surface trafficking, regulation, and gating of the 
receptor (Rudolph et al., 1999; Löw et al., 2000; Crestani et al., 2002; Yee et al., 2005). Behavioral 
analysis of H/R knock-in mice for each the four  subunit variants assembled in diazepam-sensitive 
GABAARs revealed loss of specific effects of diazepam, which allowed to classify the contribution of 
each subtype to the spectrum of diazepam’s effects. Thus, sedation only involves 1-GABAARs, 
whereas anxiolysis occurs upon allosteric modulation of 2-GABAARs, and when stress is involved, 
partially 3-GABAARs (reviewed in (Rudolph & Möhler, 2004)). More recent studies have shown a 
corresponding segregation of other effects of diazepam (and midazolam), including benzodiazepine 
addiction (Tan et al., 2010), tachypnea (Masneuf et al., 2012), and anti-hyperalgesia (Knabl et al., 
2008), to specific GABAAR subtypes. Importantly, electrophysiological analyses confirmed that the 
point-mutations are functionally silent. However, in 5(H105R)-mutants, it leads to decreased 
expression of 5-GABAARs, which is behaviorally significant (Prut et al., 2010) (see Box 3).  
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A distinction of GABAAR subtypes based on the  subunit variants is less straightforward, in particular 
because each  subunit can be associated with various a subunits. Nevertheless, 3 subunit-
containing GABAARs selectively mediate the action of intravenous general anesthetics, as well as part 
of the effects of pentobarbital, as shown in 3(N265M) mutant mice (Jurd et al., 2003; Zeller et al., 
2007). In addition, neuron-specific deletion of these receptors curtails survival beyond early postnatal 
age in the majority of mutant mice (Ferguson et al., 2007). 
Taken together, these findings are of fundamental relevance not only for the development of 
efficacious benzodiazepine site-ligands devoid of unwanted side-effects (in particular, sedation), but 
also to investigate how neuronal circuits are being assembled during brain development and regulated 
by plasticity mechanisms in adulthood. 
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Box 3: Extrasynaptic GABAA receptors 
Tonic inhibition, mediated by persistent activation of extrasynaptic GABAARs, is an important 
determinant of neuronal excitability and is increasingly recognized to play a key role in mediating 
effects of neurosteroids, as well as to contribute to pathophysiology of major disease states (reviewed 
in (Belelli et al., 2009; Gunn et al., 2011; Brickley & Mody, 2012)). While tonic inhibition is widely 
considered to reflect receptor activation by ambient GABA, this vision has been questioned by 
evidence that spontaneous openings of GABAARs might contribute to most of tonic currents that can 
be recorded in dentate gyrus granule cells (Wlodarczyk et al., 2013). Extrasynaptic receptors 
containing the  subunit have a very high affinity to GABA, and mediate most actions of neurosteroids, 
and thus contribute to regulate brain activity under circumstances when their synthesis is increased, 
including stress, delivery, ethanol intoxication (Sarkar et al., 2011; Carver & Reddy, 2013). These 
receptors are selectively modulated by the super-agonist gaboxadol (but insensitive to classical 
benzodiazepine agonists) (Mortensen et al., 2010). Until recently, it was unclear how the expression 
and cell surface expression of extrasynaptic receptors is regulated. Evidence now indicates that tonic 
inhibition in the dentate gyrus and thalamus is modulated by PKA and PKC activity (targeting 4-
GABAAR) (Connelly et al., 2013a), for example upon stimulation of GABAB receptors (Connelly et al., 
2013b; Tao et al., 2013). Specifically, PKC-mediated phosphorylation of Ser443 in the 4 subunit was 
shown to enhance cell surface expression and activity of these receptors (Abramian et al., 2010). 
However, another study contends that PKC activation reduces tonic inhibition in the thalamus by 
targeting the 2 subunit (Bright & Smart, 2013). As tonic inhibition is a major determinant of neuronal 
excitability, these data unravel novel, albeit contradictory, mechanisms that potentially have major 
effects on network activity. 
Besides 4// receptors, 5-GABAARs (most probably composed of 5/3/2 subunits) also form a 
prominent population of extrasynaptic receptors in the hippocampal formation, olfactory bulb, and 
cerebral cortex. These receptors are modulated by diazepam, but insensitive to zolpidem. Interest in 
these receptors was triggered by the observations in 5(H105R)-mutant mice (carrying diazepam-
insensitive 5-GABAARs, see Box 2) that they do not develop tolerance to the sedative (i.e., motor 
impairing) action of diazepam (van Rijnsoever et al., 2004). Furthermore, 5(H105R)-mutant mice 
exhibited ~30% reduction in 5-GABAARs but displayed improved performance in a hippocampus-
dependent memory task (trace fear conditioning) compared to wildtype mice (Crestani et al., 2002). 
This observation opened the tantalizing perspective that reducing the function of 5-GABAARs might 
be exploited to reverse disease-related deficits in cognition and memory performance, and triggered 
the search for inverse agonists acting selectively at these receptors (reviewed in (Rudolph & Möhler, 
2013)). However, a more systematic analysis of 5(H105R)-mutant mice revealed increased basal 
locomotion and altered memory for location of objects, indicative of hippocampal dysfunction (Prut et 
al., 2010). Therefore, the reduced expression of 5-GABAAR induces complex bidirectional changes in 
behavioral performance in these mutants. 
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Other receptors, presumably containing the 2 subunit, as revealed by their sensitivity to diazepam, 
are located extrasynaptically and mediate tonic inhibition. They include in particular 3-GABAAR in the 
basolateral amygdala (Marowsky et al., 2012) and the inferior olivary nucleus (Devor et al., 2001). The 
rules governing the extrasynaptic localization of these receptors are not understood. The majority of 
3-GABAARs, notably in thalamic reticular neurons or in hippocampal or cerebellar interneurons, form 
postsynaptic clusters associated with gephyrin (Studer et al., 2006; Schneider Gasser et al., 2007; 
Notter et al., 2013). Whereas interactions with gephyrin are thought to be crucial for postsynaptic 
receptors, other mechanisms remaining to be explored, might supersede them to determine (and 
maintain) 3-GABAARs at extrasynaptic sites in specific neuron populations. A similar dichotomy also 
exist for 5-GABAARs, which are not strictly extrasynaptic in the hippocampal formation (Serwanski et 
al., 2006); those located extrasynaptically were shown to interact with radixin, a phospho-protein 
belonging to the ezrin-radixin-meosin  protein family and interacting with the actin cytoskeleton 
(Loebrich et al., 2006). 
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Box 4: GABAA receptor-mediated “excitation” 
GABAARs being selectively permeable for Cl
 and HCO3
 ions (Kaila, 1994), there is now a large 
consensus that elevation of the intracellular concentration of either species might result in a 
depolarizing current upon GABAAR activation, and thereby potentially “excite” this neuron (Blaesse et 
al., 2009). There is ample evidence for GABAAR-mediated depolarization of immature (and mature) 
neurons and NG2 cells, leading to Ca
2+
-influx; opening the door to speculating about the roles of Ca
2+
 
as second messenger in these cells, in particular to control the cell cycle and differentiation 
mechanisms (Tanaka et al., 2009; Merz et al., 2011; Young et al., 2012). It has also been proposed 
that GABAAR-mediated excitation precedes (and is replaced by) glutamatergic transmission during 
maturation of cortical neurons (Hennou et al., 2002), and that “excitatory” GABA drives giant 
depolarizing potentials, which are network phenomena thought to contribute to proper axonal wiring of 
the developing CNS (reviewed in (Dehorter et al., 2012)).  
The reality of GABAAR-mediated excitation in vivo has been much debated, as well as its functional 
significance and the main ion species responsible for it. In particular, there is often confusion about the 
excitatory effects of depolarizing GABA. Considering that one of the main effect of GABAAR activation 
is a net increase in membrane conductance, opposing the depolarizing effect of positive charge influx 
induced by any other neurotransmitter. Therefore, while a neuron can be depolarized by GABA, this 
does not necessarily translate as being “excited”.  
The prevalent view is that GABA-induced depolarization is due to high expression of the co-transporter 
NKCC1 and low expression of KCC2, which exert opposing action on intracellular Cl. Nevertheless, in 
mature neurons (expressing high levels of KCC2), intense GABAAR stimulation can lead eventually to 
neuronal depolarization due to KCC2-mediated K
+
 efflux (Viitanen et al., 2010). This biphasic 
response, which involves short-lasting changes in ionic driving force of GABAAR and reduces the 
efficacy of diazepam (Deeb et al., 2013), has been coined as “short-term ionic plasticity” (Raimondo et 
al., 2012). Despite the importance of NKCC1 and KCC2 for regulating GABA function, in particular 
under pathological conditions such as epilepsy and chronic pain, little is known about their precise 
subcellular localization and functional regulation. Evidence is now emerging that transcriptional and 
post-translational mechanisms, involving among others BDNF signaling, have major impact on the 
availability and cell surface expression of KCC2 (Yeo et al., 2009; Lee et al., 2011; Puskarjov et al., 
2012; Chamma et al., 2013; Sun et al., 2013). Furthermore, it is now being recognized that, besides 
NKCC1 and KCC2, the developmental maturation of carbonic anhydrases is a major determinant of 
the driving force of GABAARs in immature brain (Rivera et al., 2005). Thus, absence of carbonic 
anhydrase (upon targeted gene deletion) enhances depolarizing action of GABA and induces seizures 
in neonatal mice (Ruusuvuori et al., 2013). Finally, it should be emphasized that, unlike initial 
speculations that the depolarizing and hyperpolarizing effects of GABA might be mediated by distinct 
GABAAR subtypes, there is no evidence supporting this possibility. These speculations were triggered, 
in part, by observations that the subunit composition of major GABAAR subtypes changes drastically, 
in particular in neocortex and thalamus, during the phase of synaptogenesis (see main text). However, 
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this subunit switch appears to be unrelated to GABA depolarization, and its significance remains 
matter of speculation. 
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Table 1: Consequences of altered GABAergic function for neurodevelopmental and 
psychiatric disorders 
Possible causes Functional 
consequences 
Functional deficit, 
disorder 
Selected 
references 
Reduced GABA synthesis, 
defective maturation of 
interneurons, altered 
excitatory-inhibitory balance 
Abnormal 
opening/duration of 
critical windows of 
plasticity 
Sensory, motor, or 
cognitive (e.g., 
language) deficits 
(Hensch, 2005; 
Ehninger et al., 
2008; Bavelier et 
al., 2010) 
Mutations affecting 
extracellular matrix proteins, 
synapse formation and 
transcription factors; defective 
neurotrophin signaling 
Anormal neuronal 
migration, interneuron 
differentiation, 
synapse formation 
(e.g., axon-initial 
segment) 
Epilepsy, 
schizophrenia 
 
(Lewis et al., 2005; 
Galanopoulou, 
2010; Heinrich et 
al., 2011; Marín, 
2012) 
Mutations affecting genes 
involved in synaptogenesis 
(e.g., NLGNs), defective 
postsynaptic scaffold formation 
and intracellular signaling, 
impaired excitatory-inhibitory 
balance 
Altered intracellular 
signaling, impaired 
dendrite development, 
spine maturation, 
reduced synaptic 
plasticity 
Intellectual 
disabilities, 
Angelman 
syndrome, autism-
spectrum disorders 
(Südhof, 2008; 
Blundell et al., 
2009; Shen & 
Scheiffele, 2010; 
Pizzarelli & 
Cherubini, 2011) 
Altered expression of GABAAR 
subunit genes, early-life 
stress, defective BDNF 
signaling 
Abnormal GABAAR 
function at critical 
stages of brain 
development 
Anxiety disorders, 
major depression 
(Hong et al., 2008; 
Maguire & Mody, 
2009; Shen et al., 
2012; Smith, 2013; 
Vithlani et al., 
2013) 
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Figure legends 
Figure 1 
Differential distribution of GABAAR  subunit variants in the adult mouse forebrain. A-E: Each panel 
depicts in false colors, ranging from dark blue to red, orange, yellow, and white for maximal intensity, 
the relative staining intensity pattern of each subunit indicated, as determined by immunoperoxidase 
staining. 6 is not depicted, because it is not expressed in the forebrain. Note that each subunit has a 
unique distribution pattern, with partial overlap and complementarity to other  subunits. F: Main 
anatomical structures present in the images of panels A-E (ac, anterior commissure; cc, corpus 
callosum; AON, anterior olfactory nucleus; CA1, CA1 region of the hippocampus; CPu, caudate 
nucleus and putamen (= striatum); DG, dentate gyrus; GPe, globus pallidus, external; IC, inferior 
colliculus; nRT, thalamic reticular nucleus; OB, olfactory bulb; Pi, piriform cortex; Po, pontine nuclei; 
S1 primary somato sensory cortex; SC, superior colliculus; SNc, substantia nigra, pars reticulata; Su, 
subiculum; VP, ventral pallidum; VPL, ventral postero-lateral thalamic nucleus. Scale bar, 2 mm. 
Adapted from (Panzanelli et al., 2011). 
Figure 2 
Distinction of postsynaptic and extrasynaptic GABAARs detected by immunofluorescence staining and 
confocal laser scanning microscopy. The subcellular localization is based on the identification of 
postsynaptic sites positive for gephyrin and presynaptic GABAergic terminals positive for VGAT. A: 2 
subunit staining in adult mouse CA1, revealing numerous brightly stained clusters around pyramidal 
cell bodies in the stratum pyramidale (sp) and on their dendrites in stratum oriens (so) and radiatum 
(sr). A1-A4: High magnification images taken from a section triple stained for 2 (red), gephyrin 
(yellow), and VGAT (blue) in stratum radiatum, depicting in single, double, and triple staining that 2 
clusters are colocalized with gephyrin (A3; yellow) and apposed to VGAT-positive terminals (A2). B: 
5 subunit staining in adult mouse CA1,depicting the granular appearance of the staining, with 
pyramidal cells in sp appearing as lightly stained structures with an unstained nucleus. B1-B4: at 
higher magnification, the granular staining lacks bright clusters (as seen for 2 in panel A1) and shows 
no obvious relationship to gephyrin clusters (B3; green) or VGAT-positive terminals (B4; blue). Scale 
bars: A-B, 20 m; A1-A4, B1-B4, 5 m. Adapted from (Panzanelli et al., 2011). 
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Figure 3 
Schematic depiction of major postsynaptic proteins interacting with GABAARs and their putative 
organization in the PSD of a GABAergic synapse (see main text for details). A: Schematic depiction of 
key molecules of GABAergic synapses. B: Possible arrangement of gephyrin molecules, forming 
trimers as proposed from structural analysis (Sander et al., 2013), and models of scaffolding 
assembly, to which GABAARs and collybistin bind. C: Basic molecular organization of the GABAergic 
PSD, depicting the presence of NL2 (interacting with presynaptic neurexin isoforms and with 
gephyrin), collybistin splice variants, in both active and inactive conformation, and interacting with the 
small GTPases CDC-42 and/or TC-10, in addition to gephyrin and GABAARs. The exact roles of 
collybistin, and its enzymatic activity, remain hypothetical; the scheme shows a proposed function for 
gephyrin submembrane targeting, along with possible effects within the PSD itself to facilitate 
recruitment of GABAARs moving via lateral diffusion in the membrane. The size of each molecule is 
depicted roughly relative to its molecular weight. 
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Graphical abstract 
GABAA receptor heterogeneity arises through combinatorial assembly of a large family of 
subunits to generate multiple receptor subtypes. It is an important facet of the variety of 
GABAergic signaling in adult and developing CNS, and a key factor underlying GABAergic 
synaptic plasticity underlying excitatory/inhibitory balance in neuronal circuits. This review 
presents and discusses recent progress in elucidating the relevance of GABAA receptor 
heterogeneity for CNS function in health and disease. 
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